Navigation Links
Arsenal Capital Partners übernimmt führendes Unternehmen für modellbasierte Arzneimittelentwicklung Certara
Date:12/20/2013

NEW YORK, 20. Dezember 2013 /PRNewswire/ -- Arsenal Capital Partners, ein führendes Private-Equity-Unternehmen mit Sitz in New York, das in mittelständische Gesundheits- und Spezialindustrieunternehmen investiert, verkündete heute die Übernahme von Certara, dem führenden Anbieter modellbasierter Arzneimittelentwicklung, Datenanalysesoftware und Beratungsdienstleistungen für den Markt biopharmazeutischer Forschung und Entwicklung.

Certara bietet hochspezialisierte und integrierte Lösungen an, die auf rechnergestützten Modellen basieren und durch führende wissenschaftliche Beratungsdienstleistungen unterstützt werden. Sie werden für die Entdeckungsphase, die vorklinische sowie klinische Phase der Arzneimittelentwicklung angeboten. Dank der Lösungen von Certara reduzieren sich für Klienten Zeit und Kosten für die Einführung von Arzneimitteln auf den Markt maßgeblich, indem datengesteuerte Entscheidungen ermöglicht werden, die zu einem präziseren Studienaufbau mit geringerem Risiko zum Scheitern und verbesserter Sicherheit der Studiensubjekte führen – ein Vorteil der stark regulierten und zunehmend teureren Forschungs- und Entwicklungsumgebung.

Stephen McLean, ein Partner bei Arsenal und Co-Head der Healthcare Group des Unternehmens erklärte: „Wir sind über unsere Investition in dieses spannende Unternehmen, das einen solch wichtigen Beitrag zur Verbesserung der Produktivität des Arzneimittelentwicklungsprozesses leistet, hocherfreut. Die durchschnittlichen Kosten für die Forschung und Entwicklung eines neuen Arzneimittels liegen heute über 1,5 Mrd. US-Dollar und die Dauer beträgt 10 bis 15 Jahre. Das steht in einem klaren Widerspruch zur Notwendigkeit, die Kosten der globalen Gesundheitsfürsorge zu senken, und Certara wird einen we
'/>"/>

SOURCE Arsenal Capital Partners
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Arsenal Capital Partners verwerft Certara, leider in geneesmiddelontwikkeling op basis van modellen
2. Arsenal Capital Partners Acquires Leading Model-Based Drug Development Company Certara
3. Soligenix Announces Initial $600,000 Investment and up to $10.6 Million Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC
4. UCLA Venture Capital Fund Selects KYTHERA Biopharmaceuticals CEO Keith Leonard for First Annual Entrepreneurial Achievement Award
5. TVM Capital Group Announces Two-pronged Global Investment Strategy with Renewed MENA Focus
6. Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor
7. S&P Capital IQ to Share Its Views on the Biotech Bull Market During the Next "ETF Analyst Hour"
8. Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise In Series A Financing
9. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
10. GW Pharmaceuticals to Present at the 2013 Aegis Capital Healthcare Conference
11. Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... PA (PRWEB) July 25, 2014 The ... Call for Topics for Conferee Networking. These two-hour sessions ... interests to meet and resolve problems, discuss new techniques, ... The deadline to submit a topic for consideration is ... pittcon.org . The Conferee Networking committee will review ...
(Date:7/25/2014)... BENSALEM, Pa. , July 25, 2014 /PRNewswire-iReach/ ... services and consulting for global corporations operating in ... will host its first annual Global User Group ... in historic Philadelphia, Pennsylvania ... Photo - http://photos.prnewswire.com/prnh/20140724/130263 ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
(Date:7/24/2014)... , July 24, 2014  Now available is ... home. Rehealth Regenerative Therapies , located in ... other physically active people a new health option: ... Regardless of age, countless patients suffer from joint and ... such as muscle tears, torn rotator cuff, tennis elbow, ...
Breaking Biology Technology:Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3
... Largest Technology Matchmaking Event in the US Comes to Houston, ... 3-7, 2009 at the George R. Brown Convention Center, ... (NSTI), and the Clean Technology and Sustainable Industries,Organization (CTSI), today ... place May 3-7, 2009 at the George R. Brown,Convention Center ...
... New Boston Area Facility, NEW YORK, Oct. 27 ... is pioneering the pre-disease collection,processing and long-term storage of ... it has closed on a private placement financing,in the ... in launching,its adult stem cell collection network in the ...
... one Silver Bernays Mark of Merit award, for superior ... Industry Organization,s (BIO) 2008 BIO International Convention. The ... awards for the media kit it developed for Ichor ... in support of the Transportation Corridor Agencies, Toll Road ...
Cached Biology Technology:TechConnect World 2009 Matches Tomorrow's Technology Solutions with Today's Business Needs for Clean-Technology, Biotechnology and Nanotechnology 2TechConnect World 2009 Matches Tomorrow's Technology Solutions with Today's Business Needs for Clean-Technology, Biotechnology and Nanotechnology 3NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc. 2NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc. 3Gable PR Honored by PRSA San Diego Chapter with Three Awards for Client Programs 2Gable PR Honored by PRSA San Diego Chapter with Three Awards for Client Programs 3
(Date:7/28/2014)... statistical tools to map social connections in prairie ... techniques, shedding light on prairie dog communities that ... and guide future conservation efforts. The work was ... and the National Evolutionary Synthesis Center (NESCent). , ... to bubonic plague," says Dr. Jennifer Verdolin, lead ...
(Date:7/27/2014)... in vitro study has revealed that nicotine and cotinine, ... caused by a certain carcinogen in smoke. , The ... of tobacco leaves and ultimately ends up in the ... lung and liver, where it is activated by a ... in mice has revealed that nicotine can partially interfere ...
(Date:7/27/2014)... In one of the largest prevalence studies to date, ... genotype prevalence estimates for the hepatitis C virus (HCV). ... Association for the Study of Liver Diseases, indicate that ... 83 million patients infected of which one-third reside in ... cases, is the next most prevalent, followed by genotypes ...
Breaking Biology News(10 mins):Social network research may boost prairie dog conservation efforts 2Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2Hepatitis C virus genotype 1 is most prevalent worldwide 2
... Scientists here have made a major discovery that sheds ... natural killer (NK) cells, powerful but somewhat mysterious components ... line of defense against cancer and infectious diseases. , ... are generated in bone marrow, but Michael Caligiuri, director ...
... vanishingly small realm of molecules and atoms may not ... after all. In fact, research at the National Institute ... version of the optical microscope might be able to ... fraction of the wavelength of visible light. , In ...
... Center scientists have discovered a potential new drug that ... one-third of all cancers. The scientists showed they could ... this new compound, called cysmethynil. , Their finding, reported ... the National Academy of Sciences, is the first step ...
Cached Biology News:Scientists identify new model Of NK cell development 2Scientists identify new model Of NK cell development 3Devising Nano Vision for an Optical Microscope 2Newly Discovered Compound Blocks Known Cancer-Causing Protein 2Newly Discovered Compound Blocks Known Cancer-Causing Protein 3
... GI Number: 4503277 Accession ... Description: FUNCTION: Supplies the nucleotide substrate ... + H 2 O = dUMP ... SIMILARITY: Belongs to the Diseases: Benign ...
Active GST Protein...
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
DNA Purification...
Biology Products: